Zacks Research Brokers Lower Earnings Estimates for PBYI
Puma Biotechnology, Inc. (NASDAQ:PBYI – Free Report) – Equities research analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Puma Biotechnology in a research report issued to clients and investors on Wednesday, April 30th. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will post earnings per share […]
Puma Biotechnology, Inc. (NASDAQ:PBYI – Free Report) – Equities research analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Puma Biotechnology in a research report issued to clients and investors on Wednesday, April 30th. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will post earnings per share […]
